Literature DB >> 18612555

Heparin is procoagulant in the absence of antithrombin.

Stephanie A Smith, James H Morrissey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18612555      PMCID： PMC2572225          DOI： 10.1160/TH08-05-0275

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  11 in total

1.  Polyphosphate modulates blood coagulation and fibrinolysis.

Authors:  Stephanie A Smith; Nicola J Mutch; Deepak Baskar; Peter Rohloff; Roberto Docampo; James H Morrissey
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

Review 2.  Inorganic polyphosphate: a molecule of many functions.

Authors:  A Kornberg; N N Rao; D Ault-Riché
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Fucosylated chondroitin sulfate as a new oral antithrombotic agent.

Authors:  Roberto J C Fonseca; Paulo A S Mourão
Journal:  Thromb Haemost       Date:  2006-12       Impact factor: 5.249

Review 4.  Biochemical and pharmacologic heterogeneity in low molecular weight heparins. Impact on the therapeutic profile.

Authors:  Jawed Fareed; Debra Hoppensteadt; Christopher Schultz; Qing Ma; Michelle Florian Kujawski; Brian Neville; Harry Messmore
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

5.  Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.

Authors:  T Kojima; C W Leone; G A Marchildon; J A Marcum; R D Rosenberg
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

Review 6.  Heparan sulfate-protein interactions--a concept for drug design?

Authors:  Ulf Lindahl
Journal:  Thromb Haemost       Date:  2007-07       Impact factor: 5.249

7.  Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).

Authors:  Tongyao Liu; Ciaran D Scallan; George J Broze; Susanna Patarroyo-White; Glenn F Pierce; Kirk W Johnson
Journal:  Thromb Haemost       Date:  2006-01       Impact factor: 5.249

Review 8.  The anti-inflammatory effects of heparin and related compounds.

Authors:  Edward Young
Journal:  Thromb Res       Date:  2007-08-28       Impact factor: 3.944

9.  Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.

Authors:  A E Mast; G J Broze
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

10.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.

Authors:  J A Marcum; D H Atha; L M Fritze; P Nawroth; D Stern; R D Rosenberg
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157
View more
  8 in total

1.  Novel family of insect salivary inhibitors blocks contact pathway activation by binding to polyphosphate, heparin, and dextran sulfate.

Authors:  Patricia H Alvarenga; Xueqing Xu; Fabiano Oliveira; Andrezza C Chagas; Clarissa R Nascimento; Ivo M B Francischetti; Maria A Juliano; Luiz Juliano; Julio Scharfstein; Jesus G Valenzuela; José M C Ribeiro; John F Andersen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-03       Impact factor: 8.311

Review 2.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

3.  TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.

Authors:  Jeremy P Wood; Helle H Petersen; Bingke Yu; Xiaoai Wu; Ida Hilden; Alan E Mast
Journal:  Blood Adv       Date:  2017-12-26

Review 4.  New insights into the biology of tissue factor pathway inhibitor.

Authors:  S A Maroney; A E Mast
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

5.  Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.

Authors:  Jeremy P Wood; Matthew W Bunce; Susan A Maroney; Paula B Tracy; Rodney M Camire; Alan E Mast
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

6.  Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.

Authors:  Jeremy P Wood; Lisa M Baumann Kreuziger; Umesh R Desai; Alan E Mast
Journal:  Br J Haematol       Date:  2016-06-15       Impact factor: 6.998

7.  Colloidal Confinement of Polyphosphate on Gold Nanoparticles Robustly Activates the Contact Pathway of Blood Coagulation.

Authors:  Magdalena Szymusiak; Alexander J Donovan; Stephanie A Smith; Ross Ransom; Hao Shen; Joseph Kalkowski; James H Morrissey; Ying Liu
Journal:  Bioconjug Chem       Date:  2015-12-15       Impact factor: 4.774

Review 8.  Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.

Authors:  Alan E Mast
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-24       Impact factor: 8.311
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.